- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Contaminated cough syrup tragedy: NHRC steps in, demands investigation

New Delhi: The National Human Rights Commission (NHRC) has issued a call to action, demanding an investigation into the alleged deaths of children linked to contaminated cough syrup. The commission has issued notices to the state governments of Madhya Pradesh, Rajasthan, and Uttar Pradesh, directing them to probe the shocking claims and immediately ban the sale of spurious medicines.
In a bold move, the NHRC has also ordered key national health authorities, including the Drugs Controller General of India (DCGI), the Central Drugs Standard Control Organisation (CDSCO), the Directorate General of Health Services (DGHS) and the Union health ministry to order an investigation into the supply of spurious drugs and instruct all regional labs in states to collect the samples of spurious drugs and submit test reports.
"The authority is also directed to order all the Chief Drugs Controllers in the concerned states to process immediately banning of the spurious drugs and submit reports," the National Human Rights Commission (NHRC) said in a notice.
Read also: AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours
Additionally, the Director of Public Health, Telangana, has also instructed all District Medical and Health Officers (DM&HOs) to actively sensitise the public about the alert, which was originally issued on September 4 by the Drugs Control Administration (DCA).
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

